KEPHA NYANGWESO: Open Payments
NPI 1891355178 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,941 in 103 payments from 4 companies in 2025. Trend: 2023 $2,439 · 2024 $2,036 · 2025 $2,941
Food & beverage: $2,709Education: $232
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 35 | $981 |
| Otsuka America Pharmaceutical, Inc. | 28 | $731 |
| Teva Pharmaceuticals USA, Inc. | 16 | $630 |
| ACADIA Pharmaceuticals Inc | 24 | $600 |
Products named: REXULTI, INGREZZA, NUPLAZID, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
